WHO seal: Covaxin may be missing the USFDA ballast

WHO experts to reconvene for final risk-benefit study on November 3

Comments

Popular posts from this blog

Infosys lays off hundreds after failing internal assessments in Mysuru

Congress groomed me not to sit at home: Shivakumar

Greater Bengaluru Committee proposes seven municipal corporations